- Home
- BCRX vs CHCO Comparison
BCRX vs CHCO Comparison
Compare BCRX & CHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- CHCO
- Stock Information
- Founded
- BCRX 1986
- CHCO 1957
- Country
- BCRX United States
- CHCO United States
- Employees
- BCRX N/A
- CHCO N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- CHCO Major Banks
- Sector
- BCRX Health Care
- CHCO Finance
- Exchange
- BCRX Nasdaq
- CHCO Nasdaq
- Market Cap
- BCRX 1.7B
- CHCO 1.8B
- IPO Year
- BCRX 1994
- CHCO N/A
- Fundamental
- Price
- BCRX $7.86
- CHCO $117.50
- Analyst Decision
- BCRX Buy
- CHCO Hold
- Analyst Count
- BCRX 6
- CHCO 3
- Target Price
- BCRX $15.67
- CHCO $118.00
- AVG Volume (30 Days)
- BCRX 3.6M
- CHCO 78.9K
- Earning Date
- BCRX 05-05-2025
- CHCO 04-22-2025
- Dividend Yield
- BCRX N/A
- CHCO 2.69%
- EPS Growth
- BCRX N/A
- CHCO 3.68
- EPS
- BCRX N/A
- CHCO 7.89
- Revenue
- BCRX $450,712,000.00
- CHCO $291,751,000.00
- Revenue This Year
- BCRX $27.66
- CHCO $4.67
- Revenue Next Year
- BCRX $13.59
- CHCO $2.42
- P/E Ratio
- BCRX N/A
- CHCO $14.89
- Revenue Growth
- BCRX 36.00
- CHCO 1.79
- 52 Week Low
- BCRX $4.03
- CHCO $97.50
- 52 Week High
- BCRX $9.50
- CHCO $137.28
- Technical
- Relative Strength Index (RSI)
- BCRX 46.95
- CHCO 48.09
- Support Level
- BCRX $7.44
- CHCO $116.84
- Resistance Level
- BCRX $8.12
- CHCO $121.00
- Average True Range (ATR)
- BCRX 0.27
- CHCO 2.07
- MACD
- BCRX 0.03
- CHCO 0.29
- Stochastic Oscillator
- BCRX 71.74
- CHCO 50.35
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About CHCO City Holding Company
City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.